Beta-1,3-N-acetylglucosaminyltransferases (B3GNTs), a subgroup of glycosyltransferases, are linked to the onset and progression of several diseases, including autoimmune disorders, cancers, neurodevelopmental conditions, musculoskeletal disorders, and metabolic diseases (32). This evidence concerns the gene B3GNT2 and metabolic disease.